SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending following a strong earnings report, with many analysts raising their price targets and the community buzzing about the company's dominance in AI. Discussions revolve around whether the AI sector is in a bubble, the impact of potential US-Saudi investment, and the sustainability of Nvidia's growth.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart's trending status is fueled by strong earnings results and an increased full-year outlook, leading to community excitement. The company's decision to transfer its stock exchange listing to Nasdaq is also a hot topic. Community members are closely watching how these factors will influence the stock's performance.

Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL.

Safe & Green Holdings Corp

Safe & Green Holdings is trending due to community excitement around a potential short squeeze, with claims of high short interest and a low float driving significant volatility. Discussions center on holding above key price levels and pushing for substantial gains, drawing parallels to previous meme stock rallies. The community is actively encouraging each other to hold firm, anticipating a major move.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab (RKLB) is trending due to recent back-to-back Electron launches, showcasing the company's ability to scale operations. The community is focused on the launch live streams and what this increased launch cadence signals for future growth. Investors are optimistic, citing Rocket Lab's strong YTD performance and analyst price targets, positioning RKLB as a key player in the responsive space sector.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending as investors weigh potential takeover bids against concerns about shipping rates and recent earnings. Community discussions focus on the possibility of a buyout, with some speculating on potential offer prices and the board's intentions, while others express concern over the stock's recent performance and the impact of global trade dynamics.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio ($NUVB) is trending due to positive analyst updates, including a reiterated Market Outperform rating and price target from Citizens, following strong early performance of its lung cancer drug, Ibtrozi. Community members are comparing NUVB's data favorably against competitors like Nuvalent (NUVL), particularly regarding first-line ROS1 treatment, PFS, and intracranial response rates. Bullish sentiment is further fueled by upcoming catalysts, including potential EU partnership news and data on NUV-1511.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending amidst discussions about lowered revenue guidance and the impact of government delays on contract finalization, leading to debates about management's credibility. The community is weighing the company's potential in the defense sector, particularly its Black Widow drone, against concerns about production capabilities and competition. Comparisons with sector peers like Ondas are frequent, with some questioning RCAT's leadership and future prospects.

Bath & Body Works, Inc. is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. The company was founded by Leslie Herbert Wexner in 1963 and is headquartered in Columbus, OH.

Bath & Body Works Inc

BBWI is trending as investors assess its potential ahead of earnings, especially given recent analyst ratings and a new share repurchase program. The community is weighing mixed signals, from new product launches and a push into college campuses, against concerns around consumer spending and sector performance. Some see the stock as undervalued with a strong potential for a holiday season boost, while others express concerns about declining sales and increasing put options.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

PACS Group, Inc. is a holding company, which engages in the provision of post-acute healthcare facilities, professionals, and ancillary services. It provides senior care, assisted living, and independent living options in some of the communities. The company was founded by Jason Murray and Mark Hancock in 2013 and is headquartered in Farmington, UT.

PACS Group Inc.

PACS Group is trending due to a strong Q3 update and positive after-hours movement, with investors focusing on census/occupancy trends and balance sheet flexibility. The community is actively discussing the company's revenue guidance relative to competitors and potential upside based on analyst targets and healthcare expansion. Overall, there is buzz around steady inflow, healthcare expansion buzz, and the company's regained SEC compliance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments Abbott to acquire Exact Sciences, a leader in large and fast-growing...

<ul class="summary-bullets"><li>Shares moved premarket as Wall Street highlighted that a potential Abbott deal would likely require a valuation well above prior estimates.</li><li>William Blair said even conservative modeling supports a takeover price far higher than Exact Sciences’ recent trading range.</li><li>The interest comes as Abbott reportedly explores a major acquisition to expand its diagnostics footprint.</li></ul><p>Exact Sciences Corp. shares slipped over 2% in pre-market trading on Thursday even as William Blair said a potential takeover by Abbott Laboratories would “likely” need to exceed $100 per share, based on what the firm called “very conservative assumptions.” The decline came despite reports that Abbott is reportedly nearing a deal to acquire the cancer-screening company.</p><p>Exact Sciences surged 24% during Wednesday’s session, marking its biggest one-day gain in nearly 16 months. Meanwhile,&nbsp;Abbott’s&nbsp;stock fell nearly 3%.</p><h2 class="st-heading-2"><strong>William Blair Sees Takeout Well Above $80</strong></h2><p>William Blair said that Exact Sciences currently trades at just under 5x forward sales, while an acquisition would likely require a 6x to 7x sales multiple, implying a premium of over 35%. The brokerage added that its September valuation analysis already showed a fundamental path to at least $80 per share.</p><p>The firm argued that Abbott would need to offer “much more than this,” pointing to a price “likely over $100.” William Blair maintains ‘Outperform’ ratings on both Abbott and Exact Sciences.</p><h2 class="st-heading-2"><strong>Analysts See Abbott With Capacity To Strike A Blockbuster Deal</strong></h2><p>Abbott is reportedly evaluating a transaction that would significantly expand its diagnostics franchise. The company has the capacity for as much as $30 billion in debt-funded M&amp;A, supported by roughly $7 billion in annual free cash flow, according to a Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-11-19/abbott-weighs-takeover-of-cancer-test-maker-exact-sciences">report</a>.</p><p>Abbott’s diagnostics business was a major boost during the Covid-19 pandemic, but sales have since dwindled. The company has recently focused more on medical devices, with its glucose-monitoring products driving growth.</p><h2 class="st-heading-2"><strong>Cancer Screening Remains Exact Sciences’ Core Strength</strong></h2><p>Exact Sciences’ flagship colorectal screening test, Cologuard, has been used more than 20 million times since 2014. The company employs more than 6,500 people and operates nine research and lab centers across the U.S., underscoring its scale within the precision-diagnostics landscape.</p><h2 class="st-heading-2"><strong>Stocktwits Users Push For Higher Bids</strong></h2><p>On Stocktwits, Abbott saw ‘neutral’ sentiment on ‘normal’ message volume, while Exact Sciences drew ‘extremely bullish’ sentiment amid ‘extremely high’ volume.</p><p>One user said, “If<a href="https://stocktwits.com/symbol/ABT"> $ABT</a> is serious, they need to offer 25-30 billion.<a href="https://stocktwits.com/symbol/EXAS"> $EXAS</a> Shouldn't sell for less.”</p><p><stembedurl>https://stocktwits.com/ABinterceptor/message/636831161</stembedurl></p><p>Another user said, “I dare another large diagnostics to start a bidding war. Where else can you get underpenetrated CRC market leader and MCED in the same market place? Another big player can bring in more salesforce and larger marketing budget to bring Cologuard 1.0 and 2.0 to the next level.”</p><p><stembedurl>https://stocktwits.com/Jasooon/message/636852465</stembedurl></p><p>While&nbsp;<a href="https://stocktwits.com/symbol/EXAS">Exact Sciences’ stock</a> has risen 24% so far in 2025, Abbott’s stock has declined 3% over the same period.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, Exact Sciences logo of a molecular diagnostics company is seen on a smartphone and a pc screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

 Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover

William Blair said even conservative modeling supports a takeover price far higher than Exact Sciences’ recent trading range.

Equity

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Vanguard Group Inc. Buys 2,977,715 Shares of Abbott Laboratories $ABT

Vanguard Group Inc. raised its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 1.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities...

BSX's Neuromodulation Prospect Looks Strong: What's Behind It?

Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.

Empowered Funds LLC Has $13.80 Million Stake in Abbott Laboratories $ABT

Empowered Funds LLC boosted its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 100.1% during the second quarter, according to its most recent Form 13F filing with the...

Abbott Laboratories $ABT Holdings Lowered by America First Investment Advisors LLC

America First Investment Advisors LLC decreased its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 1.2% during the 2nd quarter, according to the company in its most recent...

Should You Continue to Hold Hologic Stock Post Q4 Earnings?

HOLX's solid Q4 growth and a pending $18.3B buyout sharpen its focus as the company prepares to end its publicly traded chapter.

Abbott Laboratories $ABT Shares Bought by Frank Rimerman Advisors LLC

Frank Rimerman Advisors LLC grew its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 33.6% in the 2nd quarter, according to the company in its most recent filing with the...

ABT Crosses Above Key Moving Average Level

In trading on Monday, shares of Abbott Laboratories (Symbol: ABT) crossed above their 200 day moving average of $131.11, changing hands as high as $131.81 per share. Abbott Laboratories shares are...

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

ABT
Abbott Laboratories

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABT News

ABTAbbott Laboratories